Amy Branson

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

Elizabeth Bancroft, Elizabeth Page, Mark N. Brook et al. · The Lancet Oncology · 2021 · 93 citations · Full text

Life Sciences, Genetics, Oncology +17

Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial

Dean A. Fennell, Amy King, Seid Mohammed et al. · The Lancet Oncology · 2022 · 81 citations · Full text

Medicine, Oncology, Pharmacology +8

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text

Medicine, Oncology, Surgery +15

A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma

Min Zhang, Aleksandra Bzura, Essa Y. Baitei et al. · Nature Communications · 2024 · 28 citations · Full text

Medicine, Immunology, Oncology +17

Personalised Exercise-Rehabilitation FOR people with Multiple long-term conditions (PERFORM): protocol for a randomised feasibility trial

Sharon Simpson, Rachael A Evans, Hannah R. Gilbert et al. · BMJ Open · 2024 · 11 citations · Full text

Medicine, Health Sciences, Rehabilitation Medicine +17